At your first vaccination appointment, you should get a CDC COVID-19 Vaccination Record card that tells you what COVID-19 vaccine you received, the date you received it, and where you received it. Keep your CDC COVID-19 Vaccination Record card for future use.
VAMS is a vaccine appointment scheduling system that your health department, employer, or provider may be using to manage vaccine appointments. V-safe is a smartphone-based tool that uses text messaging and web surveys to provide personalized health check-ins after you receive a COVID-19 vaccination.
COVAX is the vaccines pillar of the Access to COVID-19 Tools (ACT) AcceleratorThe ACT Accelerator is a ground-breaking global collaboration to accelerate the development, production, and equitable access to COVID-19 tests, treatments, and vaccines.
Efficacy is the degree to which a vaccine prevents disease, and possibly also transmission, under ideal and controlled circumstances – comparing a vaccinated group with a placebo group. Effectiveness meanwhile refers to how well it performs in the real world.
Some people may be at risk for an adverse reaction because of an allergy to one of the vaccine components or a medical condition. This is referred to as a medical exemption. Some people may decline vaccination because of a sincerely held religious belief. This is referred to as a religious exemption.
An immediate allergic reaction happens within 4 hours after getting vaccinated and could include symptoms such as hives, swelling, and wheezing (respiratory distress).
COVAX is the vaccines pillar of the Access to COVID-19 Tools (ACT) Accelerator. The ACT Accelerator is a ground-breaking global collaboration to accelerate the development, production, and equitable access to COVID-19 tests, treatments, and vaccines.
The COVAX Facility is the global pooled procurement mechanism for COVID-19 vaccines through which COVAX will ensure fair and equitable access to vaccines for all 190 participating economies, using an allocation framework formulated by WHO.
COVAX aims to accelerate the development and manufacturing of COVID-19 vaccines, and guarantee fair and equitable access for every country. COVAX is co-led by the Coalition for Epidemic Preparedness Innovations (CEPI), Gavi and WHO, with UNICEF as a key delivery partner and PAHO as the procurement agent in the Americas.
Efficacy refers to how well a vaccine performs under ideal conditions as reflected in a careful clinical trial.
COVID-19 vaccines are effective, but studies have shown vaccine protection declines over time especially with the Omicron variant. Learn more about getting a booster shot to enhance or restore protection against COVID-19.
While fully vaccinated people are less likely to transmit the coronavirus to unvaccinated people, it is still possible to spread the virus. Please get tested if you are experiencing COVID-19 symptoms, even after you are fully vaccinated.